Stay updated on Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial

Sign up to get notified when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page header revision label was updated from v3.4.1 to v3.4.2 (v3.4.1 removed).
    Difference
    0.1%
    Check dated 2026-02-12T03:49:28.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T01:30:59.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a glossary display option, the 'Last Update Submitted that Met QC Criteria' entry, the 'No FEAR Act Data' section, and a 'Revision: v3.4.0' note. Removed the older 'Last Update Submitted that met QC Criteria' entry, the 'No FEAR Act data' label, and the 'Revision: v3.3.4' note.
    Difference
    0.2%
    Check dated 2026-01-28T21:13:24.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now shows revision tag v3.3.4 replacing v3.3.3; this is a metadata update and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:57:52.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Footer updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T22:19:28.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    The page revision updated from v3.2.0 to v3.3.2, reflecting a minor label change with no impact on study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:53:15.000Z thumbnail image

Stay in the know with updates to Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.